ACE and metabolic dysfunction-associated steatotic liver disease: At baseline, statins and antihypertensive drugs (diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs)) were slightly less commonly prescribed in the NAFLD cohort than in the non-NAFLD cohort.